Priapisms during neuroleptic drug administration (3 cases)
Bourgeois, M.
La Nouvelle Presse Medicale 1(17): 1161
1972
ISSN/ISBN: 0301-1518 PMID: 5035403 Document Number: 50154
Document emailed within 1 workday
Related Documents
Fukuchi, S. 1988: Drug administration schedule of anti-ulcer agents to prevent recurrence of peptic ulcer; administration of synergistic drugs for protective factors in peptic ulcer--criteria of drug selection according to clinical symptoms and administration methods Nihon Rinsho. Japanese Journal of Clinical Medicine 46(1): 119-123von Magnus, M.; Kaaber, K. 1998: Guidelines on drug administration and patient self administration of drugs. Sundhedsstyrelsen (Health Administration) Sygeplejersken 98(9): 32-35
Shannak, K.S.; Hornykiewicz, O. 1980: Brain monoamines in the rhesus monkey during long-term neuroleptic administration Advances in Biochemical Psychopharmacology 24: 315-323
Meyers, C.; Lhoas, J.P.; Huvelle, R. 1972: Rediscovery of a neuroleptic drug in a new form: clopenthixol Schweizerische Rundschau für Medizin Praxis 61(26): 869-871
Sakkas, P.; Davis, J.M.; Janicak, P.G.; Wang, Z.Y. 1991: Drug treatment of the neuroleptic malignant syndrome Psychopharmacology Bulletin 27(3): 381-384
Van Sweden, B. 1984: REM-latency in neuroleptic drug withdrawal. A case report Acta Psychiatrica Belgica 84(3): 235-239
Berrios, G.E. 1982: Neuroleptic-refractory patients and their drug plasma levels L'Encephale 8(4): 465-485
Lisoprawski, A. 1983: Drug abuse experience and neuroleptic prescriptions at the onset of schizophrenia La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 59(25): 1925-1927
Patel, A.L.; Shaikh, W.A.; Khobragade, A.K.; Soni, H.G.; Joshi, A.S.; Sahastrabuddhe, G.S. 2008: Electroconvulsive therapy in drug resistant neuroleptic malignant syndrome Journal of the Association of Physicians of India 56: 49-50
Desai, N.D.; Mundra, V.K.; Gore, Y.S.; Diwan, P.J.; Jaydeokar, S.S.; Jain, V.; Sutharsan, R.; Agarwal, A.; Moulick, N.D.; Manocha, S.M. 1998: Neuroleptic malignant syndrome: an experience of four cases Journal of the Association of Physicians of India 46(7): 653-654
Uchida, S.; Honda, F.; Otsuka, M.; Satoh, Y.; Mori, J.; Ono, T.; Hitomi, M. 1979: Pharmacological study of [2-chloro-11-(2-dimethylaminoethoxy) dibenzo[b,f]thiepine] (zotepine), a new neuroleptic drug Arzneimittel-Forschung 29(10): 1588-1594
Elie, R.; Gagnon, M.A.; Gauthier, R.; Jéquier, J.C. 1975: Effects of neuroleptic withdrawal on the drug-induced extrapyramidal syndrome of chronic schizophrenia L'Union Medicale du Canada 104(6): 909-914
2009: Aripiprazole and adolescent schizophrenia: a simple neuroleptic. No comparison with standard neuroleptic in adolescents Prescrire international 18(104): 251
Lavie, C.J.; Olmsted, T.R.; Ventura, H.O.; Lepler, B.J. 1986: Neuroleptic malignant syndrome. An underdiagnosed reaction to neuroleptic agents? Postgraduate Medicine 80(3): 171-178
Kasantikul, D.; Kanchanatawan, B. 2006: Neuroleptic malignant syndrome: a review and report of six cases Journal of the Medical Association of Thailand 89(12): 2155-2160
Janssen, P.A.; Niemegeers, C.J.; Schellekens, K.H. 1965: Is it Possible to Predict the Clinical Effects of Neuroleptic Drugs (Major Tranquillizers) from Animal Data?i. "neuroleptic Activity Spectra" for Rats Arzneimittel-Forschung 15: 104-117
Kasantikul, D.; Kanchananakhin, P. 1999: Severe catatonia and neuroleptic malignant syndrome: report of 3 cases Journal of the Medical Association of Thailand 82(9): 942-946
Sczesni, B.; Becker, H.; Schröder, J.; Bittkau, S.; von Baumgarten, F.; Truong, D.D.; Przuntek, H. 1991: Diagnostic and therapeutic aspects of neuroleptic malignant syndrome based on 12 cases Wiener Klinische Wochenschrift 103(1): 21-26
Drtil, M.; Vinar, O.; Taussigová, D. 1973: Maintenance treatment with long-acting neuroleptic drugs in persons with disturbances of social behavior and drug dependence Activitas Nervosa Superior 15(2): 87
Nakazono, Y.; Abe, H.; Murakami, H.; Koyabu, N.; Isaka, Y.; Nemoto, Y.; Murata, S.; Tsutsumi, Y.; Ohtani, H.; Sawada, Y. 2005: Association between neuroleptic drug-induced extrapyramidal symptoms and dopamine D2-receptor polymorphisms in Japanese schizophrenic patients International Journal of Clinical Pharmacology and Therapeutics 43(4): 163-171